title: Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer.
authors.affiliation: Department of Radiation Therapy, Harvard Medical School, Boston, MA 02115.
authors.forename: J
authors.initials: J
authors.lastname: Boyages
authors.forename: A
authors.initials: A
authors.lastname: Recht
authors.forename: J
authors.initials: J
authors.lastname: Connolly
authors.forename: S
authors.initials: S
authors.lastname: Schnitt
authors.forename: M A
authors.initials: MA
authors.lastname: Rose
authors.forename: B
authors.initials: B
authors.lastname: Silver
authors.forename: J R
authors.initials: JR
authors.lastname: Harris
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D009367:Neoplasm Staging; D012307:Risk Factors; D013997:Time Factors
chemical_list: D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate